BRKR News

Key Factors

Recent Updates

Catalyst

Strong institutional inflows from medium, large, and extra-large order buckets signal confidence in BRKR.
Fundamental analysis highlights favorable asset-to-market value and profitability metrics relative to peers.

Risk

Recent technical indicators including MACD Death Cross and Long Lower Shadow signals point to a weak market trend for BRKR.
Analyst consensus is divided with two Neutral ratings and one Strong Sell rating, reflecting mixed market expectations.

Generated at22:0703/25/2026by

Aime

Newswire

13:59

Bruker stock surges 4% on new analytical systems and automation technologies.

10:03

Bruker's 15min chart sees MACD and KDJ death crosses.

08:21

Bruker Corporation (BRKR) Q4 Revenue Flat YoY, Positive Momentum Returns

14:19

Bruker's 15-min chart sees MACD Death Cross and KDJ Death Cross signals.

18:02

Bruker's Profit Cycle to Benefit from Innovation and Acquisitions: Artisan Partners

About BRKR

Charts

SectorHealthcare Equipment and Supplies

Established Date--

Listing Date04/08/2000

ExchangeNASDAQ Stock Exchange

Full-time Employees11085

Fiscal Year Ends31/12

Websitewww.bruker.com

Security TypeCommon stock

Office address40 Manning Road, Billerica, MA 01821

Business

Introduction

Bruker Corporation is incorporated in Delaware. The company is a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at the microscopic, molecular and cellular levels. Many of the company's products are used to detect, measure and visualize structural features of chemical, biological and industrial material samples. The company's products and solutions meet the rapidly growing needs of various customers in the fields of life science research, pharmaceuticals, biotechnology, applied markets, cell biology, clinical research, microbiology, in vitro diagnosis, nanotechnology and materials science research.